» Articles » PMID: 24637056

The Feasibility and Clinical Utility of Myocardial Contrast Echocardiography in Clinical Practice: Results from the Incorporation of Myocardial Perfusion Assessment into Clinical Testing with Stress Echocardiography Study

Overview
Specialty Radiology
Date 2014 Mar 19
PMID 24637056
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This prospective study investigated whether the incorporation of myocardial contrast echocardiography (MCE) into a clinical stress echocardiography service reproduces the benefits of assessing myocardial perfusion proved previously in research studies.

Methods: MCE was performed during physiologic and pharmacologic clinical stress echocardiographic studies, and the value of myocardial perfusion to the reporting echocardiologists was categorized as of benefit (subclassified as incremental benefit over wall motion [WM] or greater confidence with WM) or of no added benefit. The presence and extent of inducible ischemia by WM and myocardial perfusion were documented and correlated with angiographic results in patients who underwent cardiac catheterization.

Results: In total, 220 patients underwent simultaneous MCE during stress echocardiography by eight different operators. Overall, MCE was of benefit in 193 patients (88%), providing incremental benefit over WM in 25% and greater confidence with WM evaluation in 62%. MCE provided no added benefit in 27 patients (12%). MCE detected significantly more cases of ischemia than WM in the left anterior descending coronary artery territory (65% vs 53%, P = .02) and detected a greater ischemic burden than WM on a per patient basis (median, 5 [interquartile range, 3-8] vs 4 [interquartile range, 2-7] segments; P < .001) and across all coronary territories. MCE correctly identified a greater proportion of patients with multivessel disease than WM (76% vs 56%, P = .02) and a greater ischemic burden in patients with multivessel disease (median, 7 [interquartile range, 4-9] vs 5 [interquartile range, 1-8] segments; P < .001).

Conclusions: This prospective study is the first to demonstrate that the excellent feasibility and diagnostic utility of MCE, which have been documented in the research arena, are reproducible in the clinical arena.

Citing Articles

Microbubble Enhanced Echocardiography in Current Cardiology Practice.

Strachinaru M, Ten Cate F Rev Cardiovasc Med. 2024; 23(6):202.

PMID: 39077192 PMC: 11283996. DOI: 10.31083/j.rcm2306202.


Coronary No-Reflow after Primary Percutaneous Coronary Intervention-Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy.

Ndrepepa G, Kastrati A J Clin Med. 2023; 12(17).

PMID: 37685660 PMC: 10488607. DOI: 10.3390/jcm12175592.


The Role of Novel Cardiac Imaging for Contemporary Management of Heart Failure.

Flachskampf F, Baron T J Clin Med. 2022; 11(20).

PMID: 36294522 PMC: 9605302. DOI: 10.3390/jcm11206201.


Assessment and Treatment for Coronary Microvascular Dysfunction by Contrast Enhanced Ultrasound.

Zhan J, Zhong L, Wu J Front Cardiovasc Med. 2022; 9:899099.

PMID: 35795368 PMC: 9251174. DOI: 10.3389/fcvm.2022.899099.


Shenzhu Guanxin Recipe Granules () for Improving Exercise Tolerance in Patients with Stable Angina (SERIES Trial): A Protocol of Multicenter, Randomized, Double-Blind, Placebo Parallel Controlled Clinical Trial.

Mao S, Xu D, Dang X, Li W, Wu H Chin J Integr Med. 2018; 25(2):96-102.

PMID: 30328569 DOI: 10.1007/s11655-018-3017-z.